Advancing Pediatric Atopic Dermatitis Care Through Targeted Biologic Therapies
According to recent Medscape clinical coverage, the therapeutic landscape for moderate-to-severe pediatric atopic dermatitis is…
Curated clinical updates, research breakdowns, and expert perspectives focusing on specific pathways of childhood immune development and pathology.
According to recent Medscape clinical coverage, the therapeutic landscape for moderate-to-severe pediatric atopic dermatitis is…
When we meet a family newly navigating a juvenile idiopathic arthritis diagnosis, one of the first questions we address — often…
When a child with Crohn’s disease stops responding to a biologic, the next decision is rarely as simple as choosing a stronger…
A clinical study just published in Allergy offers one of the more practically useful data points we've seen this year in…
According to researchers at Cincinnati Children's, a common genetic configuration that raises the risk of pediatric and systemic…
A new study from Children's National, published in Pediatric Allergy and Immunology, is drawing attention to who is — and who is…
According to recent Medscape coverage, emerging insights into interorgan cross talk and the expansion of cross-border registries…
A child on a scheduled biologic wakes up with a fever, comes home from school with a productive cough, or develops a sudden rash…
For many children with juvenile idiopathic arthritis, the decision between oral and subcutaneous methotrexate is not a simple…
A new study reported by News-Medical suggests that autoimmune diseases do not scatter randomly across the genome — they form…
In pediatric rheumatology, one of the most undervalued pieces of clinical evidence is often not a lab panel or a genetic test. It…
When clinicians picture Lyme arthritis in a child, the classic image is a swollen knee that responds to a short antibiotic course…
A new case series in Frontiers in Pediatrics reminds us just how costly that confusion can be — and how the right combination of…
JIA-associated uveitis develops in roughly 10% to 15% of children diagnosed with juvenile idiopathic arthritis. In the majority…
In adolescents aged 12 years and older, an ICS/formoterol-based Track 1 approach was associated with a 30-day hospital…
A case-control study published in the European Journal of Pediatrics and reported through EMJ has caught our attention because it…
Food allergy oral immunotherapy is not a single procedure and it is not a promise of permanent tolerance. For children, it is a…
A substantial proportion of children with juvenile idiopathic arthritis remain uncontrolled after exposure to multiple biologic…
Researchers at the University of Oslo and Oslo University Hospital have reported a method to engineer monoclonal antibodies so…
According to Bioengineer.org, a new study published in Pediatric Research has profiled peripheral immune-cell subsets in children…
A new analysis from the Gabriella Miller Kids First Data Resource Center, published in the September 2026 issue of The American…
The Journal of Allergy and Clinical Immunology reports that researchers used tonsil samples from 103 children aged 1–19 years to…
When we sit down with families in those early prenatal visits, the question of food allergy prevention often surfaces with a mix…
When a child reacts to a medication in the clinic, our next move depends on how reliably we can test for the suspected allergy…
According to a recent report from Medical Xpress, decision support guidelines can safely reduce unnecessary testing in very sick…
According to CNBC, a startup is building AI tools designed to help families affected by rare diseases develop custom treatment…
Peanut allergy affects approximately 2% of the general population and up to 8% of children in Western countries. For pediatric…
Oral methotrexate has approximately 11–15% lower bioavailability than subcutaneous methotrexate at identical doses in pediatric…
According to a report from Bioengineer.org, researchers at CHOP have identified genetic differences between pediatric and adult…
In my line of work, I see clinical protocols that are meticulously designed and then routinely weakened at the point of care. JIA…
Pediatric systemic lupus erythematosus is rarely a condition that can be managed with one prescription or a short treatment…
A single oral corticosteroid dose, typically prednisone or prednisolone at 1 mg/kg at flare onset, resolves fever within 2–4…
The 2025 STOP-JIA trial results confirmed what many of us in pediatric rheumatology had suspected for years: earlier aggressive…
Approximately 50 to 60 percent of positive results on standard skin prick tests (SPT) and serum-specific IgE (sIgE) panels…
For moderate-to-severe pediatric atopic dermatitis, the treatment distinction is no longer simply topical therapy versus systemic…
For a child, stepping down asthma controller medication is usually considered only after at least six months of stable…
The 2026 American College of Rheumatology guidelines materially change several juvenile idiopathic arthritis treatment pathways…
For children with persistent allergic rhinitis, antihistamines and nasal sprays can control symptoms, but they do not change the…